PHARMA BUYL-LOUISE

Elsene ·KBO/BCE: BE 0764.926.261

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	02-06-2026	59 d early	2026-00138591
31-12-2024	31-07-2025	12-08-2025	12 d late	2025-00380330
31-12-2023	31-07-2024	02-07-2024	29 d early	2024-00231291
31-12-2022	31-07-2023	28-06-2023	33 d early	2023-00197621
31-12-2021	31-07-2022	30-05-2022	62 d early	2022-20050470

Metric	This company	Sector median	Position in the sector
Solvency	40.0%	13.8%	better than 80% of 242 sector peers
Net result	€73k	€19k	better than 71% of 242 sector peers
Equity	€152k	€94k	better than 58% of 242 sector peers
Gross operating margin	€94k	€319k	better than 20% of 214 sector peers
Total assets	€381k	€913k	better than 22% of 242 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€381k
Fixed assets	21/28	€246k
Financial fixed assets	28	€246k
Current assets	29/58	€135k
Amounts receivable within one year	40/41	€77k
Cash & bank	54/58	€8k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€381k
Equity	10/15	€152k
Contributions / capital	10/11	€25k
Accumulated profits (losses)	14	€127k
Amounts payable	17/49	€228k
Amounts payable after one year	17	€115k
Amounts payable within one year	42/48	€114k
Trade debts payable within one year	44	€893
Income statement
Gross operating margin	9900	€94k
Operating result	9901	€94k
Financial income	75	€585
Financial charges	65	€3k
Result before taxes	9903	€92k
Income taxes	67/77	€19k
Net result for the period	9904	€73k
Result to be appropriated	9905	€73k

Summary